# Verified Financial Evidence — Phase 1 Boundary Check

- **Verification date:** 2026-07-26
- **Input:** `data/raw_financials.md`
- **Status:** `CONDITIONAL — no company-level data is in scope yet`

## Verification result

The raw-financials packet correctly contains no revenue, net profit, EPS, cash-flow, order, utilization, ASP or margin values because the case had no final or provisional ticker universe at collection. The absence is explicit and is not a zero value. Therefore there is no company-level number to cross-verify at this stage.

| Check | Result | Consequence |
|---|---|---|
| Theme-universe methodology files exist | PASS | May define research coverage only. |
| Final / provisional ticker list exists | FAIL | No issuer financial collection can start. |
| Company financial datapoints are sourced and reconcilable | NOT APPLICABLE | No earnings model or valuation may be built. |
| BD contract-to-accounting bridge exists by candidate | FAIL | Innovative-drug headline values receive no earnings credit. |
| Order-to-revenue / margin bridge exists by candidate | FAIL | Semiconductor, PCB/optical and power-equipment narratives receive no earnings credit. |

## Gate consequence

This verification does not pass a model or valuation gate. After the full-chain universe identifies potential core candidates, collect issuer filings and primary contract/order evidence for each candidate, then replace this boundary check with a company-level verification packet.
